Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the ...

People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, ...

FORT MYERS, FL - April 23, 2026 - - Exert BodySculpt, a body contouring practice led by Dr. Giselle Prado-Wright, has ...

Semaglutide and tirzepatide telehealth access, compounded GLP-1 program pricing, refund terms, and weight loss medication ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

Indian pharma companies are betting on Chinese partnerships to bring oral GLP-1 drugs to market, but the window to act is ...

Novo Nordisk A/S NVO reported positive topline results from its late-stage PIONEER TEENS trial, showing that oral semaglutide ...

The rise of GLP-1 receptor agonists such as Mounjaro and Ozempic, combined with the rise of “on-the-go” consumption habits ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...